BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12187164)

  • 21. The Impact of Demographic and Socioeconomic Factors on Major Salivary Gland Cancer Survival.
    Olarte LS; Megwalu UC
    Otolaryngol Head Neck Surg; 2014 Jun; 150(6):991-8. PubMed ID: 24647644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer.
    Du XL; Fang S; Vernon SW; El-Serag H; Shih YT; Davila J; Rasmus ML
    Cancer; 2007 Aug; 110(3):660-9. PubMed ID: 17582625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
    Sher DJ; Neville BA; Chen AB; Schrag D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program.
    Tran Q; Warren JL; Barrett MJ; Annett D; Marth M; Cress RD; Deapen D; Glaser SL; Gomez SL; Schwartz SM; Li CI; Wu XC; Enewold L; Harlan LC; Rivera DR; Winn DM; Penberthy L; Cronin KA
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):72-81. PubMed ID: 32412073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement.
    Baldwin LM; Adamache W; Klabunde CN; Kenward K; Dahlman C; L Warren J
    Med Care; 2002 Aug; 40(8 Suppl):IV-82-95. PubMed ID: 12187173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated With Unplanned Hospitalizations Among Patients With Nonmetastatic Colorectal Cancers Intended for Treatment in the Ambulatory Setting.
    Fessele KL; Hayat MJ; Mayer DK; Atkins RL
    Nurs Res; 2016; 65(1):24-34. PubMed ID: 26657478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cigarette smoking and health-related quality of life in Medicare beneficiaries.
    Hays RD; Smith AW; Reeve BB; Spritzer KL; Marcus SE; Clauser SB
    Health Care Financ Rev; 2008; 29(4):57-67. PubMed ID: 18773614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing Cancer Registry Abstracted and Self-Reported Data on Race and Ethnicity.
    Atekruse SF; Cosgrove C; Cronin K; Yu M
    J Registry Manag; 2017; 44(1):30-3. PubMed ID: 29595942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Information gained from linking SEER Cancer Registry Data to state-level hospital discharge abstracts. Surveillance, Epidemiology, and End Results.
    Brooks JM; Chrischilles E; Scott S; Ritho J; Chen-Hardee S
    Med Care; 2000 Nov; 38(11):1131-40. PubMed ID: 11078053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neighborhood composition and incidence of cancer among Hispanics in the United States.
    Eschbach K; Mahnken JD; Goodwin JS
    Cancer; 2005 Mar; 103(5):1036-44. PubMed ID: 15672387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.
    Kirsner RS; Ma F; Fleming L; Federman DG; Trapido E; Duncan R; Wilkinson JD
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):769-73. PubMed ID: 16614122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors.
    Fisher ES; Wennberg JE; Stukel TA; Skinner JS; Sharp SM; Freeman JL; Gittelsohn AM
    Health Serv Res; 2000 Feb; 34(6):1351-62. PubMed ID: 10654835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
    McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
    Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicare HMOs: who joins and who leaves?
    Virnig BA; Morgan RO; DeVito CA; Persily NA
    Am J Manag Care; 1998 Apr; 4(4):511-8. PubMed ID: 10179910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dimensional variable selection and prediction under competing risks with application to SEER-Medicare linked data.
    Hou J; Paravati A; Hou J; Xu R; Murphy J
    Stat Med; 2018 Oct; 37(24):3486-3502. PubMed ID: 29845637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of melanoma follow-up trends in Medicare patients: a large scale, multi-regional analysis.
    Hashmi O; Waller JL; Turrentine JE
    Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.